<?xml version="1.0" encoding="UTF-8"?>
<p>With much of the world beginning to exit COVID-19 lockdown, there is an urgent need to test all existing antimicrobial surfaces against SARS-Cov-2 and develop new ones for rapid implementation in appropriate settings. At this juncture, given the importance of the human microbiota for health and the role that environmental microbes play in developing and maintaining that microbiota together with the potential impact of antimicrobial surfaces on AMR, the judicial use of these surfaces is an important consideration.</p>
